Experiences and preferences about information on treatment-related side effects among patients with early breast cancer
The survey underscores critical needs and offers insight informing the provision of comprehensive and timely information on treatment-related side effects across the cancer survivorship continuum.
Authors
- Angelos P. Kassianos (ORCID: https://orcid.org/0000-0001-6428-2623)
- Giuseppe Catanuto (ORCID: https://orcid.org/0000-0003-3774-8605)
- Fedro A. Peccatori (ORCID: https://orcid.org/0000-0001-8227-8740)
- Constantina Cloconi (ORCID: https://orcid.org/0000-0002-9126-8082)
- Sonia Ujupan
- Antonio Di Meglio (ORCID: https://orcid.org/0000-0002-0233-3189)
- S. Rohr
- Rebecca E. Steele (ORCID: https://orcid.org/0000-0003-4746-7348)
- Alexandre Chan (ORCID: https://orcid.org/0000-0003-4391-4219)
- Monique Coersmeyer
- Marzia Zambon
Institutions
- Inserm (FR)
- Cyprus University of Technology (CY)
- University of California, Irvine (US)
- Institut Gustave Roussy (FR)
- European Society for Paediatric Oncology (BE)
- Eli Lilly (Switzerland) (CH)
- Society of Surgical Oncology (US)
- Irvine University (US)
- Europa Donna (IT)
- European Institute of Oncology (IT)
Publication Details
- Journal
- The Breast
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1016/j.breast.2025.104414
- Citations
- 3
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Eli Lilly and Company